FLT1 and Alzheimer disease: We found that CSF levels of 5 biomarkers of neuroinflammation and cerebrovascular dysfunction (YKl-40, ICAM-1, VCAM-1, IL-15, and Flt-1) were increased in AD already during the preclinical and prodromal stages.